India's Strides Pharma hits over 7-yr high on Q1 profit
** Shares of Strides Pharma SRID.NS up 4% at record high
of 1,020.75, highest since April 2017
** Co reported Q1 profit of 702 mln rupees vs 102.4 mln
rupees year ago
** Stk up 57.4% YTD vs 28.4% gains in pharma index
.NIPHARM
(Reporting by Sethuraman NR in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees